RxDoctor Payments Data

Svetlana Grinberg

Physician Assistant · Brooklyn, NYNPI 1396982021

Payments from drug & device makers

$3,505in general payments, 2019–2025

Across 192 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$977
  • Teva Pharmaceuticals USA, Inc.$909
  • Amgen$224
  • Pfizer$202
  • Sanofi$165
  • SK Life Science, Inc.$161
  • plus $868 from 18 others

What the payments were for

  • Food & beverage$3,505100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,505 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$14,474
Medicare patients
76
Services billed
156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate126$227,528
AubagioTeriflunomide14$100,931
Emgality PenGalcanezumab-Gnlm63$41,821
Aimovig AutoinjectorErenumab-Aooe45$32,591
Dimethyl Fumarate11$16,500
QuliptaAtogepant11$11,284
Rivastigmine95$9,914
NamzaricMemantine Hcl/Donepezil Hcl16$9,605
Memantine Hcl402$6,596
Levetiracetam185$4,297
Donepezil Hcl372$3,556
Diclofenac Sodium28$3,546
Meclizine Hcl264$3,443
Gabapentin304$2,889
Nortriptyline Hcl174$1,996

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$202$227,528126 claims
SanofiAubagio$165$100,93114 claims
AbbVieQulipta, Namzaric$977$20,88827 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →